UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines

BMC cancer, 2013-02, Vol.13 (1), p.63-63, Article 63

2013

Volltextzugriff (PDF)

Whole blood clots are more resistant to lysis than plasma clots - greater efficacy of rivaroxaban

Thrombosis research, 2013-03, Vol.131 (3), p.e100-e109

2013

Volltextzugriff (PDF)

Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells

Journal of hematology and oncology, 2012-04, Vol.5 (1), p.16-16, Article 16

2012

Volltextzugriff (PDF)

Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP

Journal of cell science, 2005-01, Vol.118 (Pt 2), p.343-356

2005

Volltextzugriff (PDF)

New combinational assay using soluble fibrin and d-dimer determinations: a promising strategy for identifying patients with suspected venous thromboembolism

PloS one, 2014-03, Vol.9 (3), p.e92379-e92379

2014

Volltextzugriff (PDF)

Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy

Journal of hematology and oncology, 2013-07, Vol.6 (1), p.49-49, Article 49

2013

Volltextzugriff (PDF)

Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect

FEBS letters, 2001-04, Vol.495 (3), p.159-166

2001

Volltextzugriff (PDF)

Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models

Arteriosclerosis, thrombosis, and vascular biology, 2002-04, Vol.22 (4), p.623-629

2002

Volltextzugriff (PDF)

Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate

BMC cancer, 2010-07, Vol.10 (1), p.375-375, Article 375

2010

Volltextzugriff (PDF)

Angiostatin Gene Transfer: Inhibition of Tumor Growth in vivo by Blockage of Endothelial Cell Proliferation Associated with a Mitosis Arrest

Proceedings of the National Academy of Sciences - PNAS, 1998-05, Vol.95 (11), p.6367-6372

1998

Volltextzugriff (PDF)

Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells

Cellular signalling, 2003-03, Vol.15 (3), p.327-338

2003

Volltextzugriff (PDF)

Combined Effects of Radiotherapy and Angiostatin Gene Therapy in Glioma Tumor Model

Proceedings of the National Academy of Sciences - PNAS, 2000-06, Vol.97 (12), p.6698-6703

2000

Volltextzugriff (PDF)

Oncostatin M induces angiogenesis in vitro and in vivo

Arteriosclerosis, thrombosis, and vascular biology, 1999-08, Vol.19 (8), p.1835-1842

1999

Volltextzugriff (PDF)

Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activity

Thrombosis and haemostasis, 2007-01, Vol.97 (1), p.27-31

2007

Volltextzugriff (PDF)

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes--a possible protective mechanism against atherothrombosis

Thrombosis and haemostasis, 2000-10, Vol.84 (4), p.680-688

2000

Volltextzugriff (PDF)

Haplotypic or genotypic combinations of three protein Z polymorphisms influence protein Z plasma level

Thrombosis and haemostasis, 2009-01, Vol.101 (1), p.212-214

2009

Volltextzugriff (PDF)

Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma level

Thrombosis and haemostasis, 2009-07, Vol.102 (1), p.131-136

2009

Volltextzugriff (PDF)

Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin

Thrombosis research, 2001-05, Vol.102 (3), p.211-219

2001

Volltextzugriff (PDF)

Urokinase Antimetastatic Effects-Letter

Cancer research (Chicago, Ill.), 2016-08, Vol.76 (16), p.4909-4909

2016

Volltextzugriff (PDF)

Insights in the molecular mechanisms of the anti-angiogenic effect of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase

Thrombosis and haemostasis, 2003-03, Vol.89 (3), p.530-537

2003

Volltextzugriff (PDF)

Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma

Gastroenterology research and practice, 2010-01, Vol.2010 (2010), p.1-14

2010

Volltextzugriff (PDF)

Hyaluronectin blocks the stimulatory effect of hyaluronan-derived fragments on endothelial cells during angiogenesis in vitro

FEBS letters, 1997-11, Vol.418 (1), p.6-10

1997

Volltextzugriff (PDF)

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study

Carcinogenesis (New York), 2001-08, Vol.22 (8), p.1139-1148

2001

Volltextzugriff (PDF)

Fibrinogen αC domain: Its importance in physiopathology

Research and practice in thrombosis and haemostasis, 2019-04, Vol.3 (2), p.173-183

2019

Volltextzugriff (PDF)

Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets

Cancer letters, 2012-04, Vol.317 (2), p.207-217

2012

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(121)

Publikationsform

Artikel
(151)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Humans
(100)
Life Sciences & Biomedicine
(99)
Biological And Medical Sciences
(64)
Medical Sciences
(48)
Hematology
(45)
Cardiovascular System & Cardiology
(31)
Female
(31)
Peripheral Vascular Disease
(31)
Adult
(22)
Animals
(22)
Male
(22)
Fundamental And Applied Biological Sciences. Psychology
(19)
Oncology
(17)
Tumor Cells, Cultured
(17)
Angiogenesis
(16)
Cell Biology
(16)
Cells, Cultured
(15)
Pharmacology. Drug Treatments
(15)
Biochemistry & Molecular Biology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines

Whole blood clots are more resistant to lysis than plasma clots - greater efficacy of rivaroxaban

Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells

Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP

New combinational assay using soluble fibrin and d-dimer determinations: a promising strategy for identifying patients with suspected venous thromboembolism

Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy

Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect

Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models

Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate

Angiostatin Gene Transfer: Inhibition of Tumor Growth in vivo by Blockage of Endothelial Cell Proliferation Associated with a Mitosis Arrest

Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells

Combined Effects of Radiotherapy and Angiostatin Gene Therapy in Glioma Tumor Model

Oncostatin M induces angiogenesis in vitro and in vivo

Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activity

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes--a possible protective mechanism against atherothrombosis

Haplotypic or genotypic combinations of three protein Z polymorphisms influence protein Z plasma level

Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma level

Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin

Urokinase Antimetastatic Effects-Letter

Insights in the molecular mechanisms of the anti-angiogenic effect of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase

Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma

Hyaluronectin blocks the stimulatory effect of hyaluronan-derived fragments on endothelial cells during angiogenesis in vitro

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study

Fibrinogen αC domain: Its importance in physiopathology

Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets

Suchergebnisse filtern